---
schema_version: "secwatch.filing_event.v1"
accession: "0000883984-22-000012"
form_type: "8-K"
ticker: "ICUI"
cik: "0000883984"
company_name: "ICU MEDICAL INC/DE"
filed_at: "2022-02-24T23:59:59+00:00"
generated_at: "2026-06-27T05:10:22.072045+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# ICU Medical Q4 2021 revenue up 6% to $340.5M; GAAP EPS drops to $0.91 from $1.21

## Summary
- Revenue $340.5M vs $320.5M YoY; GAAP net income $19.9M ($0.91 diluted EPS) vs $26.1M ($1.21).
- Adjusted diluted EPS $1.82 vs $1.77; adjusted EBITDA $64.2M vs $59.8M.
- GAAP gross margin unchanged at 37%; FY2022 guidance provided in the release.

## SEC filing metadata
- accession: 0000883984-22-000012
- form_type: 8-K
- ticker: ICUI
- cik: 0000883984
- company_name: ICU MEDICAL INC/DE
- filed_at: 2022-02-24T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883984/000088398422000012/0000883984-22-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883984/000088398422000012/icui-20220224.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000883984-22-000012
- JSON: https://secwatch.observer/filing/0000883984-22-000012.json
- Plain text: https://secwatch.observer/filing/0000883984-22-000012.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.